CH611294A5 - - Google Patents

Info

Publication number
CH611294A5
CH611294A5 CH240375A CH240375A CH611294A5 CH 611294 A5 CH611294 A5 CH 611294A5 CH 240375 A CH240375 A CH 240375A CH 240375 A CH240375 A CH 240375A CH 611294 A5 CH611294 A5 CH 611294A5
Authority
CH
Switzerland
Application number
CH240375A
Inventor
Michihiro Yamamoto
Shigeaki Morooka
Masao Koshiba
Shigeho Inaba
Hisao Yamamoto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of CH611294A5 publication Critical patent/CH611294A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CH240375A 1974-02-28 1975-02-26 CH611294A5 (US08066781-20111129-C00013.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49024500A JPS5752352B2 (US08066781-20111129-C00013.png) 1974-02-28 1974-02-28

Publications (1)

Publication Number Publication Date
CH611294A5 true CH611294A5 (US08066781-20111129-C00013.png) 1979-05-31

Family

ID=12139894

Family Applications (1)

Application Number Title Priority Date Filing Date
CH240375A CH611294A5 (US08066781-20111129-C00013.png) 1974-02-28 1975-02-26

Country Status (11)

Country Link
US (1) US4179560A (US08066781-20111129-C00013.png)
JP (1) JPS5752352B2 (US08066781-20111129-C00013.png)
AU (1) AU474410B2 (US08066781-20111129-C00013.png)
BE (1) BE826052A (US08066781-20111129-C00013.png)
CA (1) CA1057752A (US08066781-20111129-C00013.png)
CH (1) CH611294A5 (US08066781-20111129-C00013.png)
DE (1) DE2508543A1 (US08066781-20111129-C00013.png)
FR (1) FR2262523B1 (US08066781-20111129-C00013.png)
GB (1) GB1456794A (US08066781-20111129-C00013.png)
NL (1) NL7502261A (US08066781-20111129-C00013.png)
SE (1) SE419866B (US08066781-20111129-C00013.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557425A1 (de) * 1975-12-19 1977-06-30 Boehringer Sohn Ingelheim Chinazolonderivate
JPS5448797A (en) * 1977-09-06 1979-04-17 Sumitomo Chem Co Ltd Tricyclic condensed pyrimidine derivative and its preparation
EP0029559A3 (en) * 1979-11-24 1981-09-30 Sandoz Ag 5,10-dihydroimidazo(2,1-b)quinazolines, their production and pharmaceutical compositions containing them
JPS62129352U (US08066781-20111129-C00013.png) * 1986-02-12 1987-08-15
WO1993003034A1 (en) * 1991-07-29 1993-02-18 Warner-Lambert Company Quinazoline derivatives as acetylcholinesterase inhibitors
CA2124306C (en) * 1993-05-26 2004-04-06 Masami Muraoka Quinazolinone derivatives
PL377933A1 (pl) * 2003-01-23 2006-02-20 Shire Holdings Ag Formulacja i sposoby leczenia trombocytemii
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US20060030574A1 (en) * 2004-08-04 2006-02-09 Shire Holdings Ag Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors
US7910597B2 (en) * 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
KR102228439B1 (ko) * 2019-08-28 2021-03-17 경남대학교 산학협력단 열전소자를 이용한 가열 및 냉각 일체형 막증발 모듈

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760013A (fr) * 1969-12-18 1971-06-08 Smith Kline French Lab Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant
US3887559A (en) * 1971-07-15 1975-06-03 Sandoz Ag Pharmacologically active tricyclic quinazolinones

Also Published As

Publication number Publication date
AU7855875A (en) 1976-07-22
SE419866B (sv) 1981-08-31
US4179560A (en) 1979-12-18
SE7502235L (US08066781-20111129-C00013.png) 1975-08-29
FR2262523A1 (US08066781-20111129-C00013.png) 1975-09-26
JPS50116496A (US08066781-20111129-C00013.png) 1975-09-11
NL7502261A (nl) 1975-09-01
JPS5752352B2 (US08066781-20111129-C00013.png) 1982-11-06
GB1456794A (en) 1976-11-24
BE826052A (fr) 1975-06-16
CA1057752A (en) 1979-07-03
DE2508543A1 (de) 1975-09-18
FR2262523B1 (US08066781-20111129-C00013.png) 1978-03-24
AU474410B2 (en) 1976-07-22

Similar Documents

Publication Publication Date Title
FR2262523B1 (US08066781-20111129-C00013.png)
AU7237274A (US08066781-20111129-C00013.png)
JPS50112681U (US08066781-20111129-C00013.png)
BR5408676U (US08066781-20111129-C00013.png)
BG23304A1 (US08066781-20111129-C00013.png)
CH574158A5 (US08066781-20111129-C00013.png)
BG19614A1 (US08066781-20111129-C00013.png)
CH49975A4 (US08066781-20111129-C00013.png)
BG20233A1 (US08066781-20111129-C00013.png)
BG20457A1 (US08066781-20111129-C00013.png)
BG20458A1 (US08066781-20111129-C00013.png)
BG20460A1 (US08066781-20111129-C00013.png)
BG20707A1 (US08066781-20111129-C00013.png)
BG20843A1 (US08066781-20111129-C00013.png)
BG20919A1 (US08066781-20111129-C00013.png)
BG21122A1 (US08066781-20111129-C00013.png)
BG21136A2 (US08066781-20111129-C00013.png)
BG21263A1 (US08066781-20111129-C00013.png)
BG21286A1 (US08066781-20111129-C00013.png)
BG21519A1 (US08066781-20111129-C00013.png)
BG21566A1 (US08066781-20111129-C00013.png)
CH564264A5 (US08066781-20111129-C00013.png)
CH573126A5 (US08066781-20111129-C00013.png)
BG26398A3 (US08066781-20111129-C00013.png)
AU481606A (US08066781-20111129-C00013.png)

Legal Events

Date Code Title Description
PL Patent ceased